A team of DZL scientists at the TLRC site has made significant progress towards a reliable, minimally invasive prediction of therapy success in patients with advanced non-small cell lung cancer (NSCLC). The innovative approach uses...
Researchers at the DZL site in Munich have discovered a promising new approach to treating pulmonary fibrosis and recently published their findings in Nature Communications. The study explores innovative strategies for treating pulmonary fibrosis.
At Justus Liebig University Giessen (JLU), a new building for the Institute for Lung Health is being constructed. This building will further strengthen Giessen as an international hub for excellent lung research.
A new research project is investigating how premature babies can be optimally supported in breathing during the first minutes after birth. Using innovative measurement methods, the aim is to better understand lung adaptation and improve...
DZL researchers have succeeded in confirming the long-term effects of dual therapy with Lumacaftor/Ivacaftor in toddlers with cystic fibrosis. Early treatment initiation significantly reduces the progression of cystic fibrosis.
The project Ai4Cilia from DZL scientist Janna Nawroth harnesses Artificial Intelligence (AI) to analyze the rhythmic motion of cilia - microscopic, hair-like structures vital to respiratory and reproductive health.
Two interdisciplinary projects of the German Centers for Health Research (DZG) are investigating the complex networks and mechanisms that control the metabolism with the aim of developing new therapeutic approaches.
DZL researcher Prof. Dr. Dr. Thomas Thum receives €800,000 from IBT Lower Saxony to develop an inhalable plant-based drug for pulmonary fibrosis. With this support, he aims to create a new, effective treatment for the...
With 103 lung transplants and one heart-lung transplant performed in 2024, the MHH leads the Eurotransplant network. The lung transplantation team relies on minimally invasive procedures and innovative approaches to improve patients' quality of life.
A team led by DZL researchers Dr. Anita Balázs and Dr. Frauke Stanke has received a €19,000 grant from the German Cystic Fibrosis Association (Mukoviszidose e.V.). The research group is investigating the role of the...
A research team at DZL site CPC-M is developing an innovative RNA-based inhalation therapy for lung diseases. The project is supported by a €2.5 million grant from the European Innovation Council.
DZL researchers have developed a new theory on the development of pulmonary arterial hypertension (PAH). The focus is on lysosomes – cellular organelles responsible for metabolism and waste disposal.
